Align Technology Price Target Raised To $300 From $250 At Piper Jaffray

Image result for Align Technology

Piper Jaffray analyst Matt O'Brien raised his price target for Align Technology (ALGN) to $300 from $250 and reiterates an Overweight rating on the shares. The maker of the Invisalign system closed yesterday up $1.40 to $253.73.

Following a call with an industry expert who runs a dental consultancy, the analyst is more constructive on the competitive advantage of Align's products and business model. Align appears to be the only company that can simultaneously treat complex cases best and produce enough volume to go after "low-hanging fruit on the simple cases,"

O'Brien tells investors in a research note. The expert told the analyst that there is not a single case Invisalign cannot do today. O'Brien continues to view the company as one of the most compelling growth stories in all of medical technology. 


How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.